ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,344.885
0.33%
Brent Oil
82.095
0.14%
Bitcoin
68,959.69
0.65%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Taysha Gene Therapies Inc (TSHA) Share Price

TSHA Taysha Gene Therapies Inc

3.27
0.31 (10.47%)
25 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Taysha Gene Therapies Inc NASDAQ:TSHA NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.31 10.47 3.27 3.14 3.26 3.27 2.93 2.94 1,900,709 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics 15.45M -111.57M -0.5967 -5.43 605.75M
 Type  Size  Price  Time  Units 
 9 25 3.14 23:55:27 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore TSHA News
14/05/202421:18EDGAR2Form 8-K - Current report
14/05/202421:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/05/202421:01GLOBETaysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update
07/05/202421:05GLOBETaysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14
03/05/202421:05GLOBETaysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
02/05/202413:00GLOBETaysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome
05/04/202413:00GLOBETaysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Period
Draw mode
Data Downloads for TSHA

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Taysha Gene Therapies Inc Articles